Servier receives Positive CHMP Opinion for Ivosidenib in Patients With IDH1-Mutated Acute Myeloid Leukemia and Bile Duct Cancer

[Anonymous]

ONCOLOGY RESEARCH AND TREATMENT, 2023; 46 (5):